Curcumin differentially regulates TGF-β1, its receptors and nitric oxide synthase during impaired wound healing

BioFactors

Volumn 16, Issue 1-2, 2002, Pages 29-43

  Mani, Haresh ^a,b   Sidhu, Gurmel S ^a   Kumari, Ranjana ^a   Gaddipati, Jaya P ^a   Seth, Pankaj ^a   Maheshwari, Radha K ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b ARMED FORCES MEDICAL COLLEGE   (India)

Author keywords

Curcumin; iNOS; TGF tIIrc; TGF tIrc; TGF 1; Wound healing

Indexed keywords

COLLAGEN; CURCUMIN; DEXAMETHASONE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; TRANSFORMING GROWTH FACTOR ALPHA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; TOPICAL TREATMENT; WOUND CLOSURE; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ANIMALIA; CURCUMA LONGA;

EID: 0036953772     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520160104     Document Type: Article

References (35)

1. H.H. Steenfos, Growth factors and wound healing, Scand J Plast Reconstr Surg Hand Surg 28 (1994), 95-105.
2. M.R. Schaffer, P.A. Efron, F.J. Thornton, K. Klingel, S.S. Gross and A. Barbul, Nitric oxide, an autocrine regulator of wound fibroblast synthetic function, J Immunol 158 (1997), 2375-2381.
3. S. Frank, M. Madlener and S. Werner, Transforming growth factors beta 1, beta 2, and beta 3 and their receptors are differentially regulated during normal and impaired wound healing, J Biol Chem 271 (1996), 10188-10193.
4. I. Arany, M.M. Brysk, H. Brysk and S.K. Tyring, Regulation of inducible nitric oxide synthase mRNA levels by differentiation and cytokines in human keratinocytes, Biochem Biophys Res Commun 220 (1996), 618-622.
5. M.T. Huang, Y.R. Lou, J.G. Xie, W. Ma, Y.P. Lu, P. Yen, B.T. Zhu, H. Newmark and C.T. Ho, Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice, Carcinogenesis 19 (1998), 1697-1700.
6. W.C. Jordan and C.R. Drew, Curcumin-a natural herb with anti-HIV activity, J Natl Med Assoc 88 (1996), 333.
7. G.S. Sidhu, A.K. Singh, D. Thaloor, K.K. Banaudha, G.K. Patnaik, R.C. Srimal and R.K. Maheshwari, Enhancement of wound healing by curcumin in animals, Wound Rep Reg 6 (1998), 167-177.
8. G.S. Sidhu, H. Mani, J.P. Gaddipati, A.K. Singh, P. Seth, K.K. Banaudha, G.K. Patnaik and R.K. Maheshwari, Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice, Wound Rep Reg 7 (1999), 362-374.
9. D. Thaloor, K.J. Miller, J. Gephart, P.O. Mitchell and G. Pavlath, Systemic administration of the NF-kB inhibitor curcumin stimulates muscle regeneration after traumatic injury, Am J Physiol 277 (1999), C320-C329.
10. R.A.F. Clark, Biology of dermal wound repair, Dermatl Clin 11 (1993), 647-666.
11. E.A. Chernoff and S. Robertson, Epidermal growth factor and the onset of epithelial epidermal wound healing, Tissue Cell 22 (1990), 123-135.
12. A. Shukla, N. Meisler and K.R. Cutroneo, Perspective article: transforming growth factor-beta: crossroad of glucocorticoid and bleomycin regulation of collagen synthesis in lung fibroblasts, Wound Repair Regen 7 (1999), 133-140.
13. H. Oxlund, I. Fogdestam and A. Viidik, The influence of cortisol on wound healing of the skin and distant connective tissue response, Surg Gynecol Obstet 148 (1979), 876-880.
14. G. Hubner, M. Brauchle, H. Smola, M. Madlener, R. Fassler and S. Werner, Differential regulation of proinflammatory cytokines during wound healing in normal and glucorticoid treated mice, Cytokine 8 (1996), 548-556.
15. J. Massague, How cells read TGF-beta signals, Nat Rev Mol Cell Biol 1 (2000), 169-178.
16. S.M. Wahl, Transforming growth factor β (TGF-β) in inflammation: a cause and a cure, J Clin Immunol 12 (1992), 61-74.
17. A.B. Roberts and M.B. Sporn, Physiological actions and clinical applications of transforming growth factor β (TGF-β), Growth Factors 8 (1993), 1-9.
18. E.J. Battegay, Angiogenesis: mechanistic insights, neovascular diseases and therapeutic prospects, J Mol Med 73 (1995), 333-346.
19. W.A. Border and E. Ruoslahti, Transforming growth factor-b in disease: the dark side of tissue repair, J Clin Invest 90 (1992), 1-7.
20. M. Leiho, O. Saksela and J. Keski-Oja, Transforming growth factor-b induction of type I plasminogen activator inhibitor, J Biol Chem 262 (1987), 17467-17474.
21. H.G. Miltenburger, W. Baschong, V. Horner and G. Marx, Cooperative effects in vitro on fibroblasts and keratinocyte functions related to wound healing by transforming growth factor- beta and a low molecular weight fraction from hemolyzed blood, Arzneimittelforschung 44 (1994), 872-876.
22. J. Gailit, M.P. Welch and R.A. Clark, TGF-beta 1 stimulates expression of kereatinocyte integrins during re-epithelialization of cutaneous wounds, J Invest Dermatol 103 (1994), 221-277.
23. C. Yamamoto, N. Ogata, X. Yi, K. Takahashi, M. Miyashiro, H. Yamada, M. Uyama and K. Matsuzaki, Immunolocalization of transforming growth factor-beta during wound repair in rat retina after laser photocoagulation, Graefes Arch Clin Exp Ophthalmol 236 (1998), 41-46.
24. S.I. Benn, J.S. Whitsitt, K.N. Broadley, L.B. Nanney, D. Perkins, L. He, M. Patel, J.R. Morgan, W.F. Swain and J.M. Davidson, Particle-mediated gene transfer with transforming growth factor-beta1 cDNAs enhances wound repair in rat skin, J Clin Invest 98 (1996), 2894-2902.
25. N. Meisler, K.A. Keefer, H.P. Ehrlich, D.R. Yager, J. Myers-Parrelli and K.R. Cutroneo, Dexamethasone abrogates the fibrogenic effect of transforming growth factor-beta in rat granuloma and granulation tissue fibroblasts, J Invest Dermatol 108 (1997), 285-289.
26. J. Slavin, J.R. Nash and A.N. Kingsnorth, Effect of transforming growth factor beta and basic fibroblast growth factor on steroid-impaired healing in intestinal wounds, Br J Surg 79 (1992), 69-72.
27. Y. Osaka, Influence of methylpredinosolone and transforming growth factor-beta on wound healing, Hokkaido Igaku Zasshi 72 (1997), 181-194.
28. R. Fassler, T. Sasaki, R. Timp, M.L. Chu and S. Werner, Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucorticoid treated mice, Exp Cell Res 222 (1996), 111-116.
29. J.M. Parrelli, N. Meisler and K.R. Cutroneo, Identification of a glucocorticoid response element in the human transforming growth factor-beta1 gene promoter, Int J Biochem Cell Biol 30 (1998), 623-627.
30. D. Kingsley, The TGF-β superfamily: new members, new receptors and new genetic tests of function in different organisms, Genes Dev 8 (1994), 133-146.
31. F. Chen and R.A. Weinberg, Biochemical evidence for the autophosphorylation and transphosphorylation of TGF-β kinases, Proc Natl Acad Sci USA 92 (1995), 1565-1569.
32. L.I. Gold, J.L. Sung, J.W. Siebert and M.T. Longaker, Type I (RI) and Type II (RII) receptors for transforming growth factor-b isoforms are expressed subsequent to transforming growth factor-b ligands during excisional wound repair, Am J Pathol 150 (1997), 209-222.
33. K. Yamasaki, H.D. Edington, C. McClosky, E. Tzeng, A. Lizonova, I. Kovesdi, D.L. Steed and T.R. Billiar, Reversal of impaired wound repair in iNOS deficient mice by topical adenoviral mediated iNOS gene transfer, J Clin Invest 101 (1998), 967-971.
34. F.J. Thornton, M.R. Schaffer, M.B. Witte, L.L. Moldawer, S.L. MacKay, A. Abouhamze, C.L. Tannahill and A. Barbul, Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds, Biochem Biophys Res Commun 246 (1998), 654-659.
35. Y. Vodovotz, Control of nitric oxide production by transforming growth factor-β1: mechanistic insights and potential relevance to human disease, Nitric oxide 1 (1997), 3-17.